Join to View Full Profile
525 E 68th StNew York, NY 10065
Phone+1 212-746-3332
Fax+1 212-746-4001
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Toshiki Takenouchi, MD is a Child Neurologist in New York, New York. He is currently licensed to practice medicine in Connecticut.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Child Neurology, 2002- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2006 - 2009
Brooklyn Hospital CenterInternship, Transitional Year, 2005 - 2006
Keio Gujuku University School of MedicineClass of 2002
Certifications & Licensure
CT State Medical License 2009 - 2027
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- Immediate Therapeutic Response to Vigabatrin in Lissencephaly-Related Epileptic Spasms due to TUBA1A R402H Variant.Toru Nagata, Takashi Shibata, Hiroki Tsuchiya, Mari Akiyama, Mitsuhiro Kato
American Journal of Medical Genetics. Part A. 2025-07-01 - 1 citationsBiallelic loss-of-function variants in the centriolar protein CCP110 leads to a ciliopathy-like phenotype.Hisato Suzuki, Yukako Muramatsu, Fuyuki Miya, Hideyuki Asada, Mamiko Yamada
European Journal of Medical Genetics. 2024-08-01 - 16 citationsGenome Analysis in Sick Neonates and Infants: High-yield Phenotypes and Contribution of Small Copy Number Variations.Hisato Suzuki, Masatoshi Nozaki, Hiroshi Yoshihashi, Kazuo Imagawa, Daigo Kajikawa
The Journal of Pediatrics. 2022-05-01
Press Mentions
Excelra Collaborates with Keio University on Drug Repurposing to Explore New Therapeutics for a Rare IndicationDecember 17th, 2019- Study Touts Rapid Genome Testing in NICUsMarch 4th, 2024
